An Evaluation of the Safety of CSF-1 in Presbyopic Subjects
Clinical trial NCT05393895 · COMPLETED
Trial details
- NCT number
- NCT05393895
- Sponsor
- Orasis Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-22
- Primary completion
- 2022-12-01
- Enrollment
- 178
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.